diethylpropion has been researched along with Weight Loss in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correr, CJ; Fernandez-Llimos, F; Lucchetta, RC; Otuki, MF; Pontarolo, R; Radominski, RB; Riveros, BS | 1 |
| Boguszewski, CL; Cunha, DR; do Desterro de Figueiredo, M; dos Santos, CM; Radominski, R; Suplicy, H | 1 |
| Elias, D; Gutierrez, R; Kalyanasundar, B; Luna, A; Moreno, MG; Perez, CI; Simon, SA; Solorio, J | 1 |
| del Valle-Laisequilla, CF; Lara-Padilla, E; Pizarro-Castellanos, M; Reyes-García, JG; Rizzoli-Córdoba, A; Rosado-Pérez, J; Soto-Molina, H | 1 |
| Gutierrez, R; Hoyo-Vadillo, C; Kalyanasundar, B; Perez, CI; Simon, SA; Solorio, J | 1 |
| Cercato, C; Halpern, A; Leança, CC; Lopes Filho, AP; Mancini, MC; Roizenblatt, VA; Segal, A | 1 |
| Delaet, D; Schauer, D | 1 |
| Andres, A; Mohundro, BL; Shaw, V; Wilbert, B | 1 |
| Astrup, AV; Breum, L; Bruun, JM; Svendsen, OL; Toubro, S | 1 |
| Dixon, JB | 1 |
| Crowder, D; Donald, JF; Molla, AL; Murphy, JE | 1 |
| Halpern, A; Mancini, MC | 1 |
5 review(s) available for diethylpropion and Weight Loss
| Article | Year |
|---|---|
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.
Topics: Appetite Depressants; Diethylpropion; Humans; Mazindol; Obesity; Overweight; Publication Bias; Reproducibility of Results; Risk Factors; Treatment Outcome; Weight Loss | 2017 |
Obesity in adults.
Topics: Adult; Diethylpropion; Gastric Bypass; Gastroplasty; Humans; Obesity; Obesity, Morbid; Phentermine; Weight Loss | 2011 |
[Drug treatment of obesity].
Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Diethylpropion; Enzyme Inhibitors; Humans; Lactones; Obesity; Orlistat; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Time Factors; Weight Loss | 2006 |
Weight loss medications--where do they fit in?
Topics: Anti-Obesity Agents; Chronic Disease; Cyclobutanes; Diethylpropion; Humans; Lactones; Obesity; Orlistat; Phentermine; Weight Loss | 2006 |
Pharmacological treatment of obesity.
Topics: Amphetamines; Anti-Obesity Agents; Appetite Depressants; Clinical Trials as Topic; Cyclobutanes; Energy Metabolism; Homeostasis; Humans; Lactones; Mazindol; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Weight Loss | 2006 |
4 trial(s) available for diethylpropion and Weight Loss
| Article | Year |
|---|---|
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.
Topics: Adult; Amphetamines; Anti-Obesity Agents; Body Mass Index; Brazil; Cyclobutanes; Diet, Reducing; Diethylpropion; Female; Fluoxetine; Follow-Up Studies; Humans; Mazindol; Obesity; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Weight Loss | 2014 |
Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial.
Topics: Adult; Appetite Depressants; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Diethylpropion; Double-Blind Method; Female; Heart Rate; Humans; Lipids; Male; Mexico; Obesity; Time Factors; Treatment Outcome; Waist Circumference; Waist-Hip Ratio; Weight Loss | 2015 |
A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.
Topics: Adult; Appetite Depressants; Body Weight; Diet, Reducing; Diethylpropion; Double-Blind Method; Female; Humans; Male; Obesity; Placebos; Treatment Outcome; Weight Loss | 2009 |
A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity.
Topics: Adult; Diethylpropion; Female; Humans; Male; Mazindol; Middle Aged; Obesity; Weight Loss | 1975 |
3 other study(ies) available for diethylpropion and Weight Loss
| Article | Year |
|---|---|
D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.
Topics: Action Potentials; Animals; Appetite Depressants; Benzazepines; Bupropion; Diethylpropion; Dopamine D2 Receptor Antagonists; Drug Interactions; Eating; Locomotion; Male; Nucleus Accumbens; Phentermine; Raclopride; Random Allocation; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sleep Initiation and Maintenance Disorders; Stereotyped Behavior; Weight Loss | 2015 |
The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction.
Topics: Animals; Appetite Depressants; Appetite Regulation; Biotransformation; Circadian Rhythm; Combined Modality Therapy; Diet, Fat-Restricted; Diet, High-Fat; Diet, Reducing; Diethylpropion; Drug Administration Schedule; Energy Intake; Half-Life; Injections, Intraperitoneal; Male; Overweight; Phenylpropanolamine; Rats, Sprague-Dawley; Weight Loss | 2016 |
Appetite suppressants as adjuncts for weight loss.
Topics: Appetite Depressants; Cardiovascular Diseases; Chemotherapy, Adjuvant; Diethylpropion; Evidence-Based Practice; Exercise; Feeding Behavior; Humans; Obesity; Pharmacovigilance; Phentermine; Treatment Outcome; Weight Loss; Weight Reduction Programs | 2011 |